ASPC 2024 Congress on CVD Prevention
Enduring Content
CLICK HERE
Session 7 - ASPC Debates
ASPC 2024 hosted three debates on Day 2 of the Scientific Sessions. Check the full session out below.
Reducing Residual CVD Risk: Adding Colchicine vs. Aggressive Lipid Lowering |
Mike Wilkinson, MD |
CAC/CCTA is the Imaging Modality of Choice in Refining ASCVD Risk in Primary Prevention |
Seamus Whelton, MD, MPH |
Lp(a) in Primary Prevention is Actionable Today |
Vera Bittner, MD, MSPH |
Satellite Symposia
At the 2024 ASPC Congress on CVD Prevention in Salt Lake City, UT, we hosted amazing Satellite Symposia on a variety of topics! Please enjoy this select enduring content, which will be available through June 2025. To view the recording of a symposium, please click on the graphics below.